Folic acid and prevention of neural tube defects

Canadian Family Physician

Volumn 54, Issue 1, 2008, Pages 36-38

  Ryan Harshman, Milly ^a   Aldoori, Walid ^b  

^a FEAST Enterprises   (Canada)

^b Wyeth Consumer Healthcare Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

DRUG MECHANISM; DRUG MEGADOSE; FOLIC ACID BLOOD LEVEL; GENE MUTATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY; PRENATAL CARE; SHORT SURVEY; VITAMIN SUPPLEMENTATION;

CANADA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; HUMANS; INCIDENCE; NEURAL TUBE DEFECTS; PREGNANCY; VITAMIN B COMPLEX;

EID: 38849091228     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Finkelstein JD, Blom HJ, Thomas CM, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 1994;43(12):1475-80.
2. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:791.
3. Green NS. Folic acid supplementation and prevention of birth defects. J Nutr 2002;(8 Suppl)132:2356S-60S.
4. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338:131-7.
5. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047-8.
6. Botto LD, Lisi A, Robert-Gnansia E, Eriskson JD, Vollset SE, Mastroiacovo P, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005;330(7491):571. Epub 2005 Feb 18.
7. Robbins JM, Cleves MA, Collins HB, Andrews N, Smith LN, Hobbs CA. Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women. Am J Obstet Gynecol 2005;192:1126-32.
8. Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: Findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 2005;73(10):679-89.
9. Hall JG. Folic acid: the opportunity that still exists. CMAJ 2000;162:1571-2.
10. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC: National Academy Press; 1997.
11. Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MGM, et al. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA 2001;286:936-43.
12. Centers for Disease Control and Prevention (CDC). Use of dietary supplements containing folic acid among women of childbearing age - United States, 2005. MMWR Morb Mortal Wkly Rep 2005;54:955-8.
13. Ashfield-Watt PAL, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG. Methylenetetrahydrofolate reductase 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: A randomized controlled trial. Am J Clin Nutr 2002;76:180-6.
14. Fohr IP, Prinz-Langenohl R, Brönstrup A, Bohlmann AM, Nau H, Berthold HK, et al. 5,10-Me thylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 2002;75:275-82.
15. Ray JC, Vermeulen MJ, Meier C, Cole DEC, Wyatt PR. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 2004;171:343-5.
16. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004;58:548-54.
17. Wilson RD, Davies G, Desilets V, Reid GJ, Summers A, Wyatt P, et al. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003;25(11):959-73.
18. Brouwer IA, van Dusseldorp M, Thomas CMG, Duran M, Hautvast JGAJ, Eskes TKAB, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomised trial. Indian Heart J 2000;52(7 Suppl):S53-8.
19. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial. Eur J Clin Nutr 2002;56(8):748-54.